Experience

Reglagene

• United States
• Biotechnology Research
• 1 - 100 Employee

• Vice President of Discovery

  • Nov 2018 - Present



BIO5, University of Arizona

• Senior Research Scientist

  • 2008 - Present



Zintro

• United States
• Information Services
• 200 - 300 Employee

• Zintro Expert

  • Jan 2013 - Oct 2017



Tetragene LLC

• Director of Medicinal Chemistry

  • Jan 2013 - Aug 2015



The University of Arizona BIO5 Drug Discovery and Development Center, Oro Valley

• Oro Valley Arizona

• Director of computational chemistry

  • Oct 2012 - Mar 2014

  • Director of computational chemistry – coordinating with medicinal chemistry and compound management group. • Development of combinatorial compound libraries (~ 10 Million : in-house, commercial, acquired and literature) for virtual screening. • Senior team leader for projects involving lead discovery and optimization of small molecules targeting protein kinases, nuclear receptors for the treatment of neurodegenerative diseases and cancer. • Team leader for medicinal chemistry project for development of small molecule inhibitors of ATPase and phosphatases. • Supervise graduate students, postdoctoral researchers and technicians for different aspects of computational and medicinal chemistry • Patent and markush search for different projects, Patent disclosure write-ups. • Directly involved in collaborations with different institutes, small and big pharmaceutical companies. Show less



University of Arizona

• United States
• Higher Education
• 700 & Above Employee

• Research Associate

  • 2003 - 2008

  • Identified small molecules for various protein targets such as AKT, PDK PH domain, urokinase using virtual screening and structure based design techniques. • Involved in the design and synthetic strategy planning of small molecules targeting c-myc transcription. • Identified small molecules for various protein targets such as AKT, PDK PH domain, urokinase using virtual screening and structure based design techniques. • Involved in the design and synthetic strategy planning of small molecules targeting c-myc transcription.



Wockhardt Ltd.

• India
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Research Scientist, Medicinal Chemistry

  • Dec 2000 - Jun 2003

  • Design and synthesis of small molecules for antibacterial and antifungal activity • Lead optimization of erythromycin class of antibacterial agents using QSAR and structure based techniques • Design and synthesis of small molecules for antibacterial and antifungal activity • Lead optimization of erythromycin class of antibacterial agents using QSAR and structure based techniques



University of Mumbai Institute of Chemical Technology

• Ph.D. Student

  • 1994 - 2000